Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
NCT ID:
NCT04682405
Group ID:
EG001
Title:
Placebo + Standard of Care Melphalan
Description:
Patients will receive six doses of placebo intravenously. The doses will begin the evening of Day -3 and continue every 12 hours through the morning of Day 0, prior to hematopoietic stem cell transplant (auto-HCT). On the evening of Day -2, patients also receive one dose of standard of care Melphalan intravenously.
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
25
Other Number Affected:
25
Other Number At Risk:
25
Study:
NCT04682405
Results Section:
NCT04682405
Adverse Events Module:
NCT04682405